GANDELLINI, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 2.626
NA - Nord America 2.512
AS - Asia 1.893
SA - Sud America 169
OC - Oceania 34
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.261
Nazione #
US - Stati Uniti d'America 2.469
CN - Cina 872
DE - Germania 786
GB - Regno Unito 507
IT - Italia 489
SG - Singapore 411
HK - Hong Kong 190
SE - Svezia 175
IN - India 154
RU - Federazione Russa 151
BR - Brasile 142
IE - Irlanda 102
NL - Olanda 91
FR - Francia 87
DK - Danimarca 78
ID - Indonesia 72
JP - Giappone 45
VN - Vietnam 34
AU - Australia 33
KR - Corea 31
AT - Austria 24
CA - Canada 24
FI - Finlandia 24
UA - Ucraina 23
PL - Polonia 18
NO - Norvegia 16
TW - Taiwan 16
TR - Turchia 14
BE - Belgio 13
MX - Messico 13
CO - Colombia 11
CH - Svizzera 8
EG - Egitto 6
ES - Italia 6
MY - Malesia 6
PH - Filippine 6
BD - Bangladesh 5
CL - Cile 5
IR - Iran 5
MM - Myanmar 5
PT - Portogallo 5
SC - Seychelles 5
ZA - Sudafrica 5
AL - Albania 4
SA - Arabia Saudita 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
GR - Grecia 3
IQ - Iraq 3
KE - Kenya 3
MA - Marocco 3
PE - Perù 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MO - Macao, regione amministrativa speciale della Cina 2
PK - Pakistan 2
RO - Romania 2
TJ - Tagikistan 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
FJ - Figi 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
NP - Nepal 1
OM - Oman 1
TN - Tunisia 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 7.262
Città #
Frankfurt am Main 649
Southend 348
Fairfield 271
Singapore 258
Chandler 223
Milan 213
Ashburn 158
Houston 148
Council Bluffs 127
Hong Kong 127
Wilmington 126
Woodbridge 120
Beijing 117
Seattle 113
Princeton 103
Dublin 102
Santa Clara 101
Cambridge 93
Ann Arbor 78
Nanjing 68
Jakarta 67
Dearborn 58
Shanghai 47
Boardman 45
Phoenix 44
Bengaluru 41
Des Moines 36
The Dalles 36
Guangzhou 35
Central District 31
Shenyang 31
Cangzhou 23
Dong Ket 22
Berlin 20
Los Angeles 20
Hangzhou 19
Jinan 19
London 19
Redwood City 19
Wuhan 19
Changsha 17
Hebei 17
Nuremberg 16
San Diego 16
Tokyo 16
Chengdu 15
Vienna 15
Nanchang 13
Seoul 13
São Paulo 13
Tianjin 13
Catania 12
Mountain View 11
Turin 11
Florence 10
Gdansk 10
Madison 10
New York 10
Rome 10
Taipei 10
Xian 10
Yubileyny 10
Zhengzhou 10
Bogotá 9
Brussels 9
Düsseldorf 9
Helsinki 9
Jacksonville 9
Ningbo 9
Silver Spring 9
Hefei 8
Jiaxing 8
Bologna 7
Chicago 7
Fuzhou 7
Grafing 7
Munich 7
Quanzhou 7
Taiyuan 7
Toronto 7
Bühl 6
Columbus 6
Costa Mesa 6
Cusano Milanino 6
Hackney 6
Harbin 6
Kent 6
Kunming 6
Melbourne 6
Miami 6
Montreal 6
Nottingham 6
Piscataway 6
Pittsburgh 6
Chongqing 5
Curitiba 5
Eitensheim 5
Evanston 5
Forlimpopoli 5
Kilburn 5
Totale 4.731
Nome #
Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay 554
miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C epsilon 323
LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation 310
MiR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCϵ and ZEB1 inhibition 262
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 237
miR-21: an oncomir on strike in prostate cancer 201
Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome 197
SPOP deregulation improves the radiation response of prostate cancer models by impairing DNA damage repair 186
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma 185
Predicting and Understanding Cancer Response to Treatment 168
Large oncosomes mediate intercellular transfer of functional microRNA 164
Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models 163
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition : persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism 158
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation 149
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development 147
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma : the role of survivin 147
MiR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells 145
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 144
MiR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts 137
Gene expression dataset of prostate cells upon MIR205HG/LEADR modulation 137
miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression 135
Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation 124
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells 120
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 119
Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms 119
Noncoding RNAs in the interplay between tumor cells and cancer-associated fibroblasts: Signals to catch and targets to hit 112
Targeting the telosome: Therapeutic implications 107
Clusterin: A potential target for improving response to antiestrogens 105
Complexity in the tumour microenvironment : cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types 103
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer 102
MicroRNAs in Cancer Management : Big Challenges for Small Molecules 99
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis 90
Navigating the Multiverse of Antisense RNAs: The Transcription- and RNA-Dependent Dimension 86
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine 84
The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action 81
Dissecting the role of microRNAs in prostate cancer metastasis : implications for the design of novel therapeutic approaches 76
miRNAs in tumor radiation response : bystanders or participants? 70
Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells 66
MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs 63
NFYA alternative cleavage and polyadenylation in cancer 62
MIR205HG/LEADR Long Noncoding RNA Binds to Primed Proximal Regulatory Regions in Prostate Basal Cells Through a Triplex- and Alu-Mediated Mechanism 62
microRNAs as players and signals in the metastatic cascade : implications for the development of novel anti-metastatic therapies 62
Targeting MicroRNAs to withstand cancer metastasis 61
MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising 59
The MYC-induced Long Non-Coding RNA MINCR as a potential novel player in cell cycle regulation in prostate cancer 58
RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy 58
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma 57
NFYC-AS1 antisense lncRNA as a potential novel player in cell cycle regulation in human cancer 54
MicroRNAs: Cobblestones on the road to cancer metastasis 54
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells 54
MicroRNAs as new therapeutic targets and tools in cancer 54
MicroRNA-Mediated Control of Prostate Cancer Metastasis: Implications for the Identification of Novel Biomarkers and Therapeutic Targets 54
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells 52
MiR-1227 targets SEC23A to regulate the shedding of large extracellular vesicles 52
The pancancer overexpressed and cell cycle regulated NFYC antisense 1 controls tumor E2F/MYC proliferation programs through in cis and in trans modes of action 52
NFYA alternative cleavage and polyadenylation in cancer 51
Senescent stroma promotes prostate cancer progression : the role of miR-210 51
Coding the noncoding: 2 years of advances in the field of microRNAs and long noncoding RNAs 50
Functional Study of the Noncoding Regulome of the Nuclear Factor Y 48
Cleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer 47
lncRNAs at the interplay between neurodegeneration and cancer: a role for MINCR 47
Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment 47
Towards the definition of prostate cancer-related microRNAs: where are we now? 46
Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications 45
Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in Malignant Pleural Mesothelioma 44
NFYA alternative cleavage and polyadenylation in cancer 39
Effective lowering of α-synuclein expression by targeting G-quadruplex structures within the SNCA gene 37
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells 36
NFYC-AS1 antisense lncRNA as a potential novel player in cell cycle regulation in human cancer 33
Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci 33
Integrating datasets to dissect NFYC-AS1 RNA- and transcription-dependent functions: comparative transcriptome profiling of knockdown strategies 27
MicroRNAs in Prostate Cancer: A Possible Role as Novel Biomarkers and Therapeutic Targets? 26
Post-transcriptional control drives Aurora kinase A expression in human cancers 22
Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype 10
LEADR, a p63 target, dampens interferon signalling in bladder cancer 2
Totale 7.621
Categoria #
all - tutte 25.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 0 0 0 0 0 0 0 38
2020/2021891 120 76 64 47 59 93 54 50 75 98 65 90
2021/2022685 41 49 35 47 60 30 41 57 85 70 51 119
2022/2023848 111 53 58 71 125 157 21 57 94 7 50 44
2023/20241.255 36 58 39 36 197 53 113 119 66 119 216 203
2024/20252.122 176 203 139 249 149 128 148 218 98 191 221 202
Totale 7.621